Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 7, 2021

View Archived Issues

4-PBA and TUDCA reduce symptoms in murine model of Alport syndrome

ADAMTS15 genetic variation causes hand and feet contractures without palmar creases

Neurons derived from iPSCs capture encoded genetic risk for Alzheimer's disease

New DGAT-2 inhibitors discovered at Inorbit Therapeutics

Boehringer Ingelheim describes new plasma kallikrein inhibitors

Monoglyceride lipase inhibitors identified at Janssen

Curadev Pharma presents new STING antagonists

Anti-VISTA antibody PMC-309 shows antitumor activity in vivo

ZEN-3694 reverses acquired resistance to CDK4/6 inhibitors in ER+ breast cancer

AI-driven discovery of novel candidates for idiopathic pulmonary fibrosis

IL-21 and IL-6 predict clinical worsening in patients with COVID-19

Analysis boosts genomics-driven precision medicine

Discovery of novel new anti-cryptosporidial lead, SLU-2633

NeuExcell, Spark Therapeutics enter collaboration to develop gene therapy for Huntington's disease

CRP, ferritin and D-dimer as biomarkers for predicting COVID-19 pneumonia progression

BCL7A predicts outcome in glioma patients

In vitro lung models of COVID-19 developed using stem cell-derived human lung organoids

Insilico Medicine and University of Cambridge collaborate on protein liquid-liquid phase separation

Adaptimmune and Genentech collaborate on allogeneic cell therapies for cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...